NoviqTech Moves to Own Core Platform IP for $67K Pending Shareholder Vote

NoviqTech (ASX: NVQ) has struck a $67,000 deal to acquire the Morphotech IP underpinning its live Carbon Central and Fuel Central platforms — but full ownership hinges on shareholder approval before 31 December 2026.
By Josua Ferreira -
  • NoviqTech has agreed to acquire software, source code, and related intellectual property from Morphotech Pte. Ltd. for AUD $67,000 plus GST, subject to shareholder approval under ASX Listing Rule 10.1.
  • The Post-Termination IP is already embedded in live, revenue-relevant operations — Carbon Central and Fuel Central are active customer platforms running on this IP right now.
  • An interim non-exclusive, royalty-free licence is effective immediately, ensuring platform continuity and protecting customer implementations while the shareholder vote is pending.
  • Shareholder approval must be obtained by 31 December 2026; if the vote fails or the deadline is missed, the interim licence terminates and NoviqTech must cease using the IP entirely.
  • The related-party trigger arises because Morphotech is associated with former NoviqTech director Freddy El Turk, who remains a related party for six months post-departure under ASX Listing Rules.
Summarise with AI:

NoviqTech moves to secure ownership of platform IP

NoviqTech Limited (ASX: NVQ) has entered into an agreement through its subsidiary NVQ Services Pty Ltd to acquire software, source code, and related intellectual property from Morphotech Pte. Ltd., a Singapore-based entity, for AUD $67,000 plus GST (if applicable), subject to shareholder approval.

The intellectual property in question, referred to in the agreement as the Post-Termination IP, is currently used in connection with the company’s Carbon Central and Fuel Central platforms and associated customer implementations. These are live, operational products, meaning the IP acquisition directly underpins existing revenue-relevant activity. The Post-Termination IP was developed by Morphotech after the termination of the Master Services Agreement (MSA) between NVQ Services and Morphotech UK on 7 April 2026.

The Carbon Central divestment that NoviqTech had previously pursued was terminated in August 2026 after ASX flagged conditions that the Board determined could not be satisfied, leaving the company retaining these software assets and resetting its strategic position around them.

Key terms of the Morphotech IP agreement

The agreement establishes a two-stage structure: an immediate interim licence to protect business continuity, followed by a conditional transfer of full ownership upon shareholder approval. The three key terms are as follows:

  • Interim Licence: Effective immediately, Morphotech grants NVQ Services a non-exclusive, royalty-free licence to access and use the Post-Termination IP. This licence remains in place until the earlier of the Post-Termination IP transfer or termination of the agreement. No consideration or other benefit is payable to Morphotech under this licence, and ownership does not transfer at this stage.

  • Conditional acquisition: Subject to Shareholder Approval, Morphotech will transfer full ownership and control of the Post-Termination IP to NVQ. The consideration payable by NVQ to Morphotech for this transfer is AUD $67,000 plus GST (if applicable), a modest outlay relative to the operational significance of the IP to live customer platforms.

  • Approval deadline: NVQ must use reasonable endeavours to obtain Shareholder Approval by 31 December 2026 (the Long-Stop Date). If shareholders reject the resolution or approval is not obtained by the Long-Stop Date, the Interim Licence automatically terminates (unless otherwise agreed), NVQ must cease use of the Post-Termination IP, Morphotech retains ownership, and no consideration is payable.

Understanding related-party rules and why shareholder approval is required

Shareholder approval is required because Morphotech Pte. Ltd. is associated with Freddy El Turk, a former NoviqTech director. Under ASX Listing Rules, a person who has ceased to be a director remains classified as a related party for six months following their departure from the board. As a result, the acquisition of the Post-Termination IP from Morphotech falls under ASX Listing Rule 10.1.

Listing Rule 10.1 requires that a listed company obtain shareholder approval before acquiring or disposing of a substantial asset involving a related party. The rule exists to protect investors from potential conflicts of interest by ensuring that shareholders have direct oversight of transactions connected to current or recently departed insiders.

This is a standard governance process rather than an indicator of any irregularity. Alongside the notice of meeting, NoviqTech is required to provide an independent expert’s report, giving shareholders access to an objective assessment of the transaction before they vote. The mechanism is designed to place decision-making power with shareholders on related-party dealings of this nature.

Next steps toward shareholder approval

The pathway to completing the IP acquisition involves several defined steps:

  1. NoviqTech intends to seek Shareholder Approval “as soon as reasonably practicable.”
  2. A notice of meeting will be issued to shareholders, accompanied by an independent expert’s report.
  3. If shareholders approve, ownership of the Post-Termination IP transfers to NVQ for $67,000 plus GST (if applicable).
  4. The Long-Stop Date for obtaining approval is 31 December 2026.

Pathway to Post-Termination IP Acquisition Timeline

In the interim, NoviqTech continues to operate Carbon Central and Fuel Central using the Post-Termination IP under the Interim Licence, ensuring that customer implementations and platform operations are unaffected while the approval process proceeds. Securing full ownership of the underlying IP is intended to provide a more stable foundation for these platforms and the company’s ongoing customer commitments.

The carbon credit offtake pathway NoviqTech is pursuing through its Coralia subsidiary, including a 12-month exclusive MOU with A Healthier Earth targeting a minimum 70% offtake of biochar credits, illustrates why maintaining stable, owned software infrastructure for Carbon Central is commercially significant to the company’s broader monetisation thesis.

Event Detail Date / Amount Status
Interim Licence effective Non-exclusive, royalty-free licence granted to NVQ Services Immediate Active
Shareholder approval deadline ASX Listing Rule 10.1 — related-party transaction approval required 31 December 2026 Pending
IP acquisition consideration Full ownership and control of Post-Termination IP transfers to NVQ $67,000 + GST (if applicable) Subject to approval

Don’t Miss the Next ASX Tech Move

Big News Blast delivers FREE breaking ASX tech news directly to your inbox within minutes of release, complete with in-depth analysis already done for you. Join 20,000+ subscribers staying ahead of the market the moment announcements drop. Click the “Free Alerts” button at StockWire X to get started today.


Frequently Asked Questions

What is the NoviqTech Morphotech IP acquisition about?

NoviqTech (ASX: NVQ) has agreed to acquire software, source code, and related intellectual property from Morphotech Pte. Ltd. for AUD $67,000 plus GST — IP that currently underpins its live Carbon Central and Fuel Central platforms — subject to shareholder approval by 31 December 2026.

Why does NoviqTech need shareholder approval to buy the Morphotech IP?

Shareholder approval is required under ASX Listing Rule 10.1 because Morphotech Pte. Ltd. is associated with Freddy El Turk, a former NoviqTech director who remains classified as a related party for six months after leaving the board.

What happens to Carbon Central and Fuel Central if shareholders reject the IP acquisition?

If shareholders vote against the resolution or approval is not obtained by 31 December 2026, the interim licence terminates, NoviqTech must cease using the Post-Termination IP, and Morphotech retains full ownership — directly affecting the platforms' operations.

What is the interim licence NoviqTech has secured from Morphotech?

The interim licence is a non-exclusive, royalty-free agreement that allows NoviqTech to continue using the Post-Termination IP immediately, with no consideration payable to Morphotech, ensuring platform continuity while the shareholder approval process is underway.

How does the Morphotech IP acquisition connect to NoviqTech's carbon credit strategy?

Carbon Central, one of the platforms running on the acquired IP, is central to NoviqTech's Coralia subsidiary and its 12-month exclusive MOU with A Healthier Earth targeting a minimum 70% offtake of biochar credits — making stable IP ownership commercially significant to that monetisation pathway.

Josua Ferreira
By Josua Ferreira
Partnership Director
Josua Ferreira holds a Bachelor of Commerce in Marketing and Advertising and brings a background in publication, business development, and ASX market storytelling. He has worked with listed companies across the resource sector and broader market, combining sharp commercial instincts with a genuine commitment to keeping investors informed.
Learn More
Companies Mentioned in Article

Breaking ASX Alerts Direct to Your Inbox

Join +20,000 subscribers receiving alerts.

Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.

About the Publisher